{"schema_version":"secwatch.filing_event.v1","accession":"0001794905-23-000021","form_type":"8-K","ticker":null,"cik":"0001794905","company_name":"Cyxtera Technologies, Inc.","filed_at":"2023-03-30T23:59:59+00:00","discovered_at":"2026-05-14T18:03:46.572969+00:00","generated_at":"2026-06-17T09:32:02.468030+00:00","sec_items":["3.01"],"event_type":"regulatory","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"Cyxtera receives Nasdaq notice for audit committee non-compliance after two director resignations","bullets":["Nasdaq notified Cyxtera on March 30, 2023 that it no longer complies with audit committee independence rules due to resignations of Melissa Hathaway and Michelle Felman.","Company has 45 calendar days to submit a plan to regain compliance; if accepted, up to 180 days to cure.","No immediate effect on listing or trading of CYXT common stock on Nasdaq Global Market.","Board is seeking to appoint new independent directors who qualify for audit committee service.","If compliance plan is not accepted, Cyxtera may appeal before a Nasdaq Hearings Panel."],"urls":{"canonical":"https://secwatch.observer/filing/0001794905-23-000021","json":"https://secwatch.observer/filing/0001794905-23-000021.json","markdown":"https://secwatch.observer/filing/0001794905-23-000021.md","text":"https://secwatch.observer/filing/0001794905-23-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1794905/000179490523000021/0001794905-23-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1794905/000179490523000021/cyxt-20230330.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-17T09:32:02.468030+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"81f79274b632a22a8d4405904f4d7d1cacc54066","claim":"Cyxtera Technologies, Inc. received a nasdaq deficiency notice notice regarding audit committee (rules 5605).","evidence_excerpt":"March 30, 2023, Cyxtera Technologies, Inc. (the “Company”) received a notice (the “Notice”) from The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that due to the resignations of Melissa Hathaway and Michelle Felman from the Company’s board of directors and audit committee, effective on March 28, 2023, the Company no longer complies with Nasdaq’s audit committee requirements as set forth in Nasdaq Listing Rules 5605, which requires an audit committee of at least three independent directors. The Notice has no immediate effect on the listing or trading of the Company’s Class A common","evidence_source":"SEC 8-K Item 3.01","evidence_url":"https://www.sec.gov/Archives/edgar/data/1794905/000179490523000021/0001794905-23-000021-index.htm","confidence":0.95,"family_label":"Listing & Compliance Notices","details":[{"label":"Exchange","value":"nasdaq"},{"label":"Notice","value":"deficiency notice"},{"label":"Deficiency","value":"audit committee"},{"label":"Rules","value":"5605"}],"fact_type":"exchange_compliance_notice"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}